Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$12.46 - $29.95 $2.22 Million - $5.34 Million
-178,437 Reduced 54.92%
146,489 $4.34 Million
Q3 2023

Nov 07, 2023

BUY
$14.09 - $19.87 $571,166 - $805,470
40,537 Added 14.25%
324,926 $5.16 Million
Q2 2023

Aug 07, 2023

BUY
$3.75 - $20.05 $160,042 - $855,693
42,678 Added 17.66%
284,389 $5.37 Million
Q1 2023

May 02, 2023

BUY
$3.67 - $4.92 $84,718 - $113,573
23,084 Added 10.56%
241,711 $928,000
Q4 2022

Jan 30, 2023

BUY
$4.55 - $6.31 $52,766 - $73,177
11,597 Added 5.6%
218,627 $1.08 Million
Q3 2022

Nov 08, 2022

SELL
$4.48 - $6.47 $3,297 - $4,761
-736 Reduced 0.35%
207,030 $990,000
Q2 2022

Aug 04, 2022

BUY
$3.15 - $5.76 $1,363 - $2,494
433 Added 0.21%
207,766 $935,000
Q1 2022

May 05, 2022

BUY
$4.26 - $7.48 $33,283 - $58,441
7,813 Added 3.92%
207,333 $987,000
Q4 2021

Feb 02, 2022

BUY
$4.75 - $7.5 $337,649 - $533,130
71,084 Added 55.35%
199,520 $1.48 Million
Q3 2021

Nov 02, 2021

SELL
$5.02 - $6.59 $167,010 - $219,242
-33,269 Reduced 20.57%
128,436 $728,000
Q2 2021

Aug 02, 2021

BUY
$5.79 - $8.6 $9,292 - $13,803
1,605 Added 1.0%
161,705 $1.07 Million
Q1 2021

May 11, 2021

BUY
$6.5 - $10.53 $27,950 - $45,279
4,300 Added 2.76%
160,100 $1.3 Million
Q4 2020

Feb 08, 2021

SELL
$3.7 - $7.66 $5,920 - $12,256
-1,600 Reduced 1.02%
155,800 $1.01 Million
Q2 2020

Aug 07, 2020

BUY
$3.32 - $5.34 $89,972 - $144,714
27,100 Added 20.8%
157,400 $724,000
Q4 2019

Feb 05, 2020

SELL
$2.25 - $5.8 $23,400 - $60,320
-10,400 Reduced 7.39%
130,300 $665,000
Q4 2018

Feb 08, 2019

SELL
$3.94 - $9.7 $9,850 - $24,250
-2,500 Reduced 1.75%
140,700 $675,000
Q3 2018

Nov 07, 2018

BUY
$8.6 - $11.26 $5,160 - $6,756
600 Added 0.42%
143,200 $1.36 Million
Q2 2018

Aug 10, 2018

BUY
$9.52 - $12.15 $348,432 - $444,690
36,600 Added 34.53%
142,600 $1.39 Million
Q1 2018

May 10, 2018

BUY
$6.7 - $12.95 $145,390 - $281,015
21,700 Added 25.74%
106,000 $1.12 Million
Q2 2017

Aug 11, 2017

BUY
N/A
84,300
84,300 $599,000

Others Institutions Holding IMGN

About ImmunoGen, Inc.


  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.